ALTRAPHARMA ApS — Credit Rating and Financial Key Figures

CVR number: 34483884
Storkevænget 9, 2840 Holte
mt@altrapharma.com
tel: 31414104

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit527.45-76.08- 171.94-66.73-42.92
Employee benefit expenses-90.57- 304.40-0.16
Total depreciation-3.56-4.75-5.93
EBIT523.89- 171.40- 482.27-66.89-42.92
Other financial expenses-0.20-1.48-3.45-0.22
Pre-tax profit523.69- 172.88- 485.71-67.12-42.92
Income taxes- 116.5627.101.30129.47
Net earnings407.14- 145.77- 484.41-67.1286.56

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Machinery and equipment10.685.93
Tangible assets total10.685.93
Investments total
Long term receivables total
Inventories total
Current trade debtors65.25
Prepayments and accrued income12.2812.55
Current other receivables6.229.885.78
Current deferred tax assets28.4128.4128.41129.47
Short term receivables total77.5340.9634.6338.29135.25
Cash and bank deposits873.04760.73214.28143.23104.42
Cash and cash equivalents873.04760.73214.28143.23104.42
Balance sheet total (assets)961.25807.63248.91181.52239.67

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital80.0080.0080.0080.0080.00
Retained earnings212.32619.45473.68-10.73-77.84
Profit of the financial year407.14- 145.77- 484.41-67.1286.56
Shareholders equity total699.45553.6869.272.1588.71
Provisions1.30
Non-current liabilities total
Current trade creditors30.1730.1730.1730.1730.17
Current owed to group member32.64149.20149.20120.79
Short-term deferred tax liabilities162.07116.56
Other non-interest bearing current liabilities69.5673.270.27
Current liabilities total261.80252.64179.64179.37150.96
Balance sheet total (liabilities)961.25807.63248.91181.52239.67
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.